Alpha-Synuclein Effects on Mitochondrial Quality Control in Parkinson’s Disease
Biomolecules · 22.12.2024 · 14 (12) · 1649
DOI: 10.3390/biom14121649 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 22.12.2024. Verfasst von Lydia Shen und 1 weiteren Autor:innen. Beteiligte Einrichtung: College of Arts & Sciences, Cornell University, Ithaca, NY 14853, USA. Hauptthemen laut MEDLINE: alpha-Synuclein, Mitochondria, Parkinson Disease. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The maintenance of healthy mitochondria is essential for neuronal survival and relies upon mitochondrial quality control pathways involved in mitochondrial biogenesis, mitochondrial dynamics, and mitochondrial autophagy (mitophagy). Mitochondrial dysfunction is critically implicated in Parkinson’s disease (PD), a brain disorder characterized by the progressive loss of dopaminergic neurons in the substantia nigra. Consequently, impaired mitochondrial quality control may play a key role in PD pathology. This is affirmed by work indicating that genes such as PRKN and PINK1, which participate in multiple mitochondrial processes, harbor PD-associated mutations. Furthermore, mitochondrial complex-I-inhibiting toxins like MPTP and rotenone are known to cause Parkinson-like symptoms. At the heart of PD is alpha-synuclein (αS), a small synaptic protein that misfolds and aggregates to form the disease’s hallmark Lewy bodies. The specific mechanisms through which aggregated αS exerts its neurotoxicity are still unknown; however, given the vital role of both αS and mitochondria to PD, an understanding of how αS influences mitochondrial maintenance may be essential to elucidating PD pathogenesis and discovering future therapeutic targets. Here, the current knowledge of the relationship between αS and mitochondrial quality control pathways in PD is reviewed, highlighting recent findings regarding αS effects on mitochondrial biogenesis, dynamics, and autophagy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Arts & Sciences, Cornell University, Ithaca, NY 14853, USA.
- Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
ORCID-Profile: Ulf Dettmer
Zitieren
APA
Shen, L., & Dettmer, U. (2024). Alpha-Synuclein Effects on Mitochondrial Quality Control in Parkinson’s Disease. Biomolecules, 14(12), 1649. https://doi.org/10.3390/biom14121649
Vancouver
Shen L, Dettmer U. Alpha-Synuclein Effects on Mitochondrial Quality Control in Parkinson’s Disease. Biomolecules. 2024;14(12):1649. doi:10.3390/biom14121649
BibTeX
@article{Shen2024,
author = {Shen, Lydia and Dettmer, Ulf},
title = {Alpha-Synuclein Effects on Mitochondrial Quality Control in Parkinson’s Disease},
journal = {Biomolecules},
year = {2024},
volume = {14},
number = {12},
pages = {1649},
doi = {10.3390/biom14121649}
}
EUVIMED